TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: static balance with open eyes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dysfunctional patterns of the lumbosacral and upper cervical spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean percentage change in weight at week 72
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants with weight reduction of 5% or more
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants with weight reduction of 20% or more
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: high-sensitivity C-reactive protein (hsCRP) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Total knowledge scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of leukocyturia
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of bacteriuria
Endpoint domain: Adverse events/effects
Primary endpoint: rate of infectious complications
Endpoint domain: Adverse events/effects
Primary endpoint: composite of cardiovascular death, nonfatal myocardial infarction, or hospitalization for unstable angina, HF, or resuscitated cardiac arrest
Endpoint domain: Mortality/survival
Primary endpoint: Natural childbirth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: adaptive coping skills
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mean bodyweight reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients reaching midtreatment
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of patients reaching treatment end point
Endpoint domain: Mortality/survival
Primary endpoint: Change in BDI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-vaccination PT-IgG seroresponse rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Restoration survival after 24 months
Endpoint domain: Mortality/survival
Primary endpoint: Cerebral events associated with snoring frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Area under the pharmacokinetic curve (AUC0−t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bioequivalence ratio (test/reference)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Susceptibility to smoke cigarettes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Future intention to smoke cigarettes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Disability assessment using Oswestry Disability Index (ODI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Opioid consumption using oral Morphine Equivalence (OME)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Willingness to enroll in a randomized clinical trial
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Perception of evidence for hydroxychloroquine prophylaxis
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Glucagon-like peptide 1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Endometrial pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood flow type
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levonorgestrel concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Reduction in mean percent area of treatment sites requiring autografting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Durable wound closure without autografting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to progression to anal cancer
Endpoint domain: Mortality/survival
Primary endpoint: objectively assessed hyperactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LAAE success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LAAE-related serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: postoperative hemoglobin (Hb)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Understanding of medication changes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Understanding of new consultations
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Communication regarding information to help make decisions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Nerve injury
Endpoint domain: Adverse events/effects
Primary endpoint: gains in language
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Herpes zoster incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Time from mivacurium withdrawal to TOFr ≥ 0.9
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time from mivacurium withdrawal to TOFr ≥ 0.7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Isotopic enrichment ratio (IER) of betaine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Subjective shared decision making
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: successful 75% reduction in cigarette consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in percentage cigarettes per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in volume of GCF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in hs-CRP concentration in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Density of EPCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proliferative vitality (optical density) of EPCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ADRs incidence during index hospitalization
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of OCD and AN pathology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality prediction based on quality of life domains
Endpoint domain: Mortality/survival
Primary endpoint: facial skin erythema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: balance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Global Evaluative Assessment of Robotic Skills scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psychological treatment effectiveness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Hepatic fat fraction (HFF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inferior displacement of the vaginal apex
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lengthening of the anterior vaginal wall
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Usability according to SUS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge transfer (average questions answered correctly)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Willingness to interact with a robot
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Thrombus size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: diet score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: target lesion failure (TLF)
Endpoint domain: Mortality/survival
Primary endpoint: Sensory perceptions predicting puff choices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily drug use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urges for sex
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feeling stressed
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean LC thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean ALCD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Average peripapillary choroidal thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Need for additional doses
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Cosmetic satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: symptomatic COVID-19
Endpoint domain: Mortality/survival
Primary endpoint: any COVID-19
Endpoint domain: Mortality/survival
Primary endpoint: mean postprandial glycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in painful arterial punctures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: any MI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: any revascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Per capita opioid consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Muscle carnosine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of the first puncture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Total puncture-localization time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Average number of fluoroscopy uses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Overall QOL score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Energy/fatigue score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: WBC (white blood cell count)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: ACTH (adrenocorticotropic hormone)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: doctor-diagnosed asthma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: persistent cough
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Postoperative use and dosage of allogeneic blood transfusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Time of TUG test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of dermatitis (total SCORAD score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: nSBFpeak
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EBV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease in binge drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intubation rate
Endpoint domain: Mortality/survival
Primary endpoint: Composite of death, myocardial infarction, and target lesion revascularization
Endpoint domain: Mortality/survival
Primary endpoint: Mean number of frailty criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of exhaustion criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of low physical activity criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of unpacked products purchased
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Responsive feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: primary adverse neonatal composite outcome
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical remission of depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical remission of anxiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum DHT increase post maximal aerobic exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Increase of TT after acute sub-maximal and maximal exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Increase of DHEAS after acute maximal aerobic exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: FSU angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intervertebral space heights (ISH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: endline infection risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Average respiratory exchange ratio (RER)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: V̇O2 during HIIE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chronic neck pain VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EQ-5D-5L scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Symptomatic Covid-19 incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Severe or critical Covid-19 cases
Endpoint domain: Adverse events/effects
Primary endpoint: Covid-19-related deaths
Endpoint domain: Adverse events/effects
Primary endpoint: Multi-organ failure (MOF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of TcPO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumor marker levels (CYFRA21‐1, CA125, VGEF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Immune levels (CD4+, CD3+, CD4+/CD8+)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Nursing compliance rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cumulative drainage fluid volume until day 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgery-related complications
Endpoint domain: Adverse events/effects
Primary endpoint: Vaginal artery circulation (PI and RI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Vaginal mucosal index (VMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaginal health index (VHI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite CRT response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean servings of fruit and discretionary food
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ADAS-cog12 score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CIBIC-Plus assessment treatment responders
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cerebral metabolic rate for glucose decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rate of acute respiratory failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Medication discrepancies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients submitting concerns
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: latency of postural responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reactive balance control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proactive postural control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum free thyroxine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: gait kinetics during terminal stance/pre-swing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gait kinetics during initial contact/loading
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of metachronous ACRN
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Acceptance and adherence to NIV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Excursion of diaphragm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subjective satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Prevalence of potentially inappropriate medications (PIMs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thrombolysis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of angiograms
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Overall SCORAD improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HAMA scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of PICC-related complications
Endpoint domain: Adverse events/effects
Primary endpoint: average cost of PICC pipeline maintenance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Patient recruitment targets
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: fertility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily insulin dosage variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: albumin-adjusted serum free thiols
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total contamination score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Time to Next Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased risk of type 2 diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of retractor adjustments
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Neurosurgeon satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: dual-task outcome measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life outcomes as measured by QLQ-C30
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Unmet need for postpartum contraception
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Average cost per client reached
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Average cost per circumcision
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Positive conversion rate of poliovirus neutralizing antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Immunogenicity profile
Endpoint domain: Adverse events/effects
Primary endpoint: Post-operative plasma vitamin C concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: less severe depressive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fabrication time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: PEDro score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peer review duration
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Negative Predictive Value (NPV) of MRI and ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Positive Predictive Value (PPV) of MRI and ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: mean cigarettes smoked per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain threshold improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Range of motion (ROM) in shoulder flexion and abduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: between-group MIDs for grass pollen allergy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: between-group MIDs for tree pollen allergy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: perioperative stroke risk
Endpoint domain: Adverse events/effects
Primary endpoint: Study retention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: reduction in parental depression levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperative bradycardia rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes